Overview
Ivan Iglesias-Sanchez practices practicing medicine in Madrid, Spain.
His clinical expertise encompasses Spinal Muscular Atrophy Type 2 and Spinal Muscular Atrophy Type 3.
He is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ivan Iglesias-Sanchez
Is Ivan Iglesias-Sanchez a top-rated expert for Spinal Muscular Atrophy Type 2?
MediFind is an objective health platform that identifies experts based on real-world data. Ivan Iglesias-Sanchez is classified as an Experienced expert for Spinal Muscular Atrophy Type 2, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ivan Iglesias-Sanchez participate in research or clinical trials?
Yes. Ivan Iglesias-Sanchez has published 26 articles and abstracts on conditions like Spinal Muscular Atrophy Type 2. You can view a list of Ivan Iglesias-Sanchez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Spinal Muscular Atrophy Type 2Mr. Iglesias-Sanchez isExperienced. Learn about Spinal Muscular Atrophy Type 2.
- Spinal Muscular Atrophy Type 3Mr. Iglesias-Sanchez isExperienced. Learn about Spinal Muscular Atrophy Type 3.